<?xml version="1.0" encoding="UTF-8"?><BillSummaries>
<item congress="114" measure-type="hr" measure-number="4669" measure-id="id114hr4669" originChamber="HOUSE" orig-publish-date="2016-03-02" update-date="2016-07-11">
<title>Advancing Standards in Regenerative Medicine Act</title>
<summary summary-id="id114hr4669v00" currentChamber="HOUSE" update-date="2016-07-11">
<action-date>2016-03-02</action-date>
<action-desc>Introduced in House</action-desc>
<summary-text><![CDATA[<p><b>Advancing Standards in Regenerative Medicine Act</b></p> This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to facilitate the establishment of a public-private Standards Coordinating Body in Regenerative Medicine and Advanced Therapies. The FDA must work with this body to develop standards to support the development and review of regenerative medicine products.]]></summary-text>
</summary>
</item>
<dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
<dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
<dc:description>This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
</dublinCore>
</BillSummaries>
